WO1996002262A3 - Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids - Google Patents

Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids Download PDF

Info

Publication number
WO1996002262A3
WO1996002262A3 PCT/US1995/009004 US9509004W WO9602262A3 WO 1996002262 A3 WO1996002262 A3 WO 1996002262A3 US 9509004 W US9509004 W US 9509004W WO 9602262 A3 WO9602262 A3 WO 9602262A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
antacids
pharmaceutical compositions
receptor antagonists
gastrointestinal distress
Prior art date
Application number
PCT/US1995/009004
Other languages
French (fr)
Other versions
WO1996002262A2 (en
Inventor
Michael Alan Brandley
Dolores Dimaria
Jeanette Louise Brandley
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Priority to AU31324/95A priority Critical patent/AU3132495A/en
Publication of WO1996002262A2 publication Critical patent/WO1996002262A2/en
Publication of WO1996002262A3 publication Critical patent/WO1996002262A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pharmaceutical compositions and methods of treatment are disclosed for providing instant and sustained relief from pain or symptoms associated with episodic heartburn or gastric distress in humans, comprising H2-receptor antagonists and antacids, more particularly compositions and methods of treatment comprising (1) nizatidine and (2) calcium carbonate or magaldrate.
PCT/US1995/009004 1994-07-20 1995-07-18 Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids WO1996002262A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU31324/95A AU3132495A (en) 1994-07-20 1995-07-18 Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27763294A 1994-07-20 1994-07-20
US08/277,632 1994-07-20

Publications (2)

Publication Number Publication Date
WO1996002262A2 WO1996002262A2 (en) 1996-02-01
WO1996002262A3 true WO1996002262A3 (en) 1997-02-13

Family

ID=23061722

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/009004 WO1996002262A2 (en) 1994-07-20 1995-07-18 Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids

Country Status (4)

Country Link
AU (1) AU3132495A (en)
CO (1) CO4410201A1 (en)
PE (1) PE33896A1 (en)
WO (1) WO1996002262A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019259791B2 (en) 2018-04-27 2024-03-28 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0492247A1 (en) * 1990-12-21 1992-07-01 Miles Inc. Effervescent H2 blocker formulation
WO1992017164A1 (en) * 1991-04-04 1992-10-15 The Procter & Gamble Company Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
WO1992017161A1 (en) * 1991-04-04 1992-10-15 The Procter & Gamble Company Chewable antacid compositions
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0492247A1 (en) * 1990-12-21 1992-07-01 Miles Inc. Effervescent H2 blocker formulation
WO1992017164A1 (en) * 1991-04-04 1992-10-15 The Procter & Gamble Company Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
WO1992017161A1 (en) * 1991-04-04 1992-10-15 The Procter & Gamble Company Chewable antacid compositions
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WASERSTEIN M ET AL: "IN-VIVO EVALUATION OF THE EFFECT OF ANTACIDS AND H-2 BLOCKERS ON INTRAGASTRIC PH IN THE GASTRIC AND DUODENAL ULCER", ACTA GASTROENTEROL LATINOAM, 15 (4). 1985 (RECD. 1986). 243-256. *

Also Published As

Publication number Publication date
WO1996002262A2 (en) 1996-02-01
AU3132495A (en) 1996-02-16
CO4410201A1 (en) 1997-01-09
PE33896A1 (en) 1996-09-02

Similar Documents

Publication Publication Date Title
AU6076198A (en) Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
CA2076648A1 (en) Composition for inducing humoral anergy to an immunogen
WO2004021872A3 (en) Tissue capturing devices
NZ332117A (en) Enteric-coated pharmaceutical compositions of mycophenolate
WO2004035754A3 (en) Microencapsulation and sustained release of biologically active polypeptides
CA2177209A1 (en) Sacro-iliac joint mobilization device
AU1030392A (en) Compositions and methods for treating gastrointestinal disorders
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
AU1030292A (en) Compositions and methods for treating gastrointestinal disorders
EP0872241A3 (en) Calcium carbonate liquid antacid compositions
IL122451A0 (en) Oxidant scavengers
BG103714A (en) Pararacetamol-containing tablet
EP0297978A3 (en) Floating sustained release therapeutic compositions
EP2295575A3 (en) Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
PT1140013E (en) SUSPENSION TABLETS ANTIACIDS FOAM FORMERS
CA2106215A1 (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
WO1996002262A3 (en) Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids
AU2001295412A1 (en) A novel polypeptide, a human cytokine receptor 10.67 and the polynucleotide encoding the polypeptide
CA2182917A1 (en) Composition and method for treating and preventing helicobactor pylori-associated stomach gastritis, ulcers and cancer
WO1994000113A3 (en) Medicaments containing 5-ht4 receptor antagonists
AU8989391A (en) Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
CA2255913A1 (en) The use of buckminsterfullerene for treatment of neurotoxic injury
EP0612527A3 (en) Use of rhamnan, rhamnose or rhamnose oligomers for the treatment of gastric ulcer.
ZA986079B (en) Polyol compounds, their production and use.
EP2025754A3 (en) Moraxella (Branhamella) catarrhalis antigens

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AM AU BB BG BR BY CA CN CZ EE FI GE HU IS JP KG KP KR KZ LK LT LV MD MG MN MX NO NZ PL RO RU SD SG SI SK TJ TM TT UA UG UZ

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AM AU BB BG BR BY CA CN CZ EE FI GE HU IS JP KG KP KR KZ LK LT LV MD MG MN MX NO NZ PL RO RU SD SG SI SK TJ TM TT UA UG UZ

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase